Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (251-260 of 306) with videos related to

Pageof 31
Sort By:
The Journal of Infectious Diseases|November 3, 2016
Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort StudySofie Hallager, Peer Brehm Christensen, Steen Ladelund, et al.
The Journal of Infectious Diseases|January 29, 2003
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virusAstrid K N Iversen, Claus Bohn Christiansen, Jørn Attermann, et al.
AIDS (London, England)|September 21, 2022
Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in DenmarkLine D Rasmussen, Susan Cowan, Jan Gerstoft, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2018
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized studyChristina Sølund, Ellen S Andersen, Belinda Mössner, et al.
AIDS and Behavior|February 2, 2017
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive PatientsLewis J Haddow, Rosanna Laverick, Marina Daskalopoulou, et al.
Plos One|December 2, 2014
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutationsChristina Sølund, Henrik Krarup, Santseharay Ramirez, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
Clinical Epidemiology|November 11, 2017
Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic responseSofie Hallager, Steen Ladelund, Peer Brehm Christensen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical AtherosclerosisJudith M Haissman, Anna K Haugaard, Andreas Knudsen, et al.
The European Respiratory Journal|June 9, 2018
Computed tomography quantification of emphysema in people living with HIV and uninfected controlsAndreas Ronit, Thomas Kristensen, Vilde S Hoseth, et al.
Pageof 31

Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|November 3, 2016
Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort StudySofie Hallager, Peer Brehm Christensen, Steen Ladelund, et al.
The Journal of Infectious Diseases|January 29, 2003
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virusAstrid K N Iversen, Claus Bohn Christiansen, Jørn Attermann, et al.
AIDS (London, England)|September 21, 2022
Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in DenmarkLine D Rasmussen, Susan Cowan, Jan Gerstoft, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2018
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized studyChristina Sølund, Ellen S Andersen, Belinda Mössner, et al.
AIDS and Behavior|February 2, 2017
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive PatientsLewis J Haddow, Rosanna Laverick, Marina Daskalopoulou, et al.
Plos One|December 2, 2014
Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutationsChristina Sølund, Henrik Krarup, Santseharay Ramirez, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
Clinical Epidemiology|November 11, 2017
Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic responseSofie Hallager, Steen Ladelund, Peer Brehm Christensen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical AtherosclerosisJudith M Haissman, Anna K Haugaard, Andreas Knudsen, et al.
The European Respiratory Journal|June 9, 2018
Computed tomography quantification of emphysema in people living with HIV and uninfected controlsAndreas Ronit, Thomas Kristensen, Vilde S Hoseth, et al.
Pageof 31